Trial
NCT01038739
Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Dr. Falk Pharma GmbH
Collaborators
—
Condition
Diverticulitis
Intervention
Mesalazine
Why stopped
Stopped due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-21